Rating Change
Citizens reiterated its Market Outperform rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
reiterateNASDAQ:PGNY
Citizens Reiterates Market Outperform Rating on Progyny, Inc. (PGNY)
Citizens reiterated its Market Outperform rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
At publication ·
What changed
Progyny, Inc. (NASDAQ:PGNY) · reiterate
- Firm
- Citizens
- Rating
- Market Outperform to Market Outperform
- Price at event
- $34.37
- Market capitalization
- $2.2B
At a glance
Key takeaways
- Citizens reiterated a Market Outperform rating on Progyny (PGNY) on November 5, 2026, with the stock trading at $34.37 and a market capitalization of $2.2 billion.
- Among the 10 most recent analyst ratings, 8 are Buy ratings and 2 are Hold ratings, with no Sell ratings.
- Progyny operates in the Healthcare sector and has recent analyst coverage from multiple firms including Wells Fargo, Leerink Partners, and Cantor Fitzgerald, all with positive ratings.
Market Context
Progyny, Inc. operates in the Healthcare sector. The stock currently trades at $34.37 with a market capitalization of $2.2B.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Progyny, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Progyny, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 05, 2026 | Wells Fargo | Overweight | N/A |
| Nov 05, 2026 | Leerink Partners | Outperform | N/A |
| Nov 05, 2026 | Citizens | Market Outperform | N/A |
| Nov 05, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Sep 30, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View PGNY Stock Page
Frequently Asked Questions
What does the Market Outperform rating mean for PGNY?
A rating of Market Outperform from Citizens reflects the analyst's outlook on Progyny, Inc. (NASDAQ:PGNY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PGNY forecast page.
Loading related coverage…